RB1CC1 and breast cancer: Recent studies have revealed that the inhibition of autophagy by FIP200 ablation suppresses mammary tumor initiation and progression, and Wang et al. established the prognostic significance of ATG5 and FIP200 in patients with breast cancer [48].